MetLife Investment Management’s Semler Scientific SMLR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-7,371
Closed -$113K 2833
2025
Q4
$113K Hold
7,371
﹤0.01% 2552
2025
Q3
$221K Buy
7,371
+2,138
+41% +$73.5K ﹤0.01% 2260
2025
Q2
$203K Buy
5,233
+1,099
+27% +$39.2K ﹤0.01% 2183
2025
Q1
$150K Buy
4,134
+1,120
+37% +$52.5K ﹤0.01% 2347
2024
Q4
$163K Buy
+3,014
New +$138K ﹤0.01% 2404
2024
Q3
Sell
-3,208
Closed -$110K 2889
2024
Q2
$110K Buy
3,208
+323
+11% +$9.3K ﹤0.01% 2561
2024
Q1
$84.3K Hold
2,885
﹤0.01% 2609
2023
Q4
$128K Hold
2,885
﹤0.01% 2483
2023
Q3
$73.2K Hold
2,885
﹤0.01% 2742
2023
Q2
$75.7K Buy
+2,885
New +$76K ﹤0.01% 2820

MetLife Investment Management's SMLR Position: Q1 2026 in Review

MetLife Investment Management sold out of Semler Scientific (SMLR) in Q1 2026, closing a stake of 7,371 shares — an estimated $113K sold.

MetLife Investment Management first reported a position in SMLR in Q2 2023 and held it in 10 quarters. The position peaked at $221K in Q3 2025. 0 funds tracked by Wall St. Rank hold SMLR as of Q1 2026.

  • MetLife Investment Management reported no remaining Semler Scientific position as of Q1 2026 after selling out during the quarter.
  • MetLife Investment Management sold 7,371 Semler Scientific shares in Q1 2026, an estimated $113K.
  • MetLife Investment Management first reported a position in Semler Scientific in Q2 2023 and held it in 10 quarters.
  • MetLife Investment Management's Semler Scientific position peaked at $221K in Q3 2025.
  • 0 funds tracked by Wall St. Rank held Semler Scientific as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.